Yes. I have a theoretical "risk of loco-regional (aka anywhere in the body) breast cancer recurrence within 9 years" of 3% if the OncotypeDX test is valid. (And two oncologists I consulted with believe it is though, as with most medical stuff, there are no guarantees).

The 3% risk assumes that I did not have radiation or chemo and take either tamoxifen or aromatase inhibitors.

My oncologist and the oncology radiologist both insisted that that 3% risk was based on my having radiation and they were both wrong. The OncotypeDX does not lead to any treatment inferences except whether the patient risk/reward profile suggested a benefit from chemo. [A low risk score does not.]

Assuming that adjuvant anti-hormone therapy reduces risk of recurrence by 40-45%, I declined the anti-hormone drugs. That would leave me with an approximate 5% recurrence risk. Or, to put it another way, a 95% chance that the cancer will not recur within 9 years.

I declined radiation as well because, before we received the Oncotype DX result, the radiologist cited the usual stats that breast cancer could recurrence in the exact same site as 10%. And radiation could reduce that to 2% statistically-speaking. But the radiation would only protect that one tiny area, not even the rest of the breast, and no other part if the body. I said "Nope" to radiation after getting the Oncotype genetic testing as I don't have the 10% general statistical risk so the risk/reward payoff for radiation wasn't there. [The major risks, in my opinion, being any radiation in the left breast being nearer the heart and lymphedema. There are other risks but these were the big two for me.